Plural CEO system favored in 21 drug firms

Published: 2013-04-04 06:56:00

Updated: 2013-04-04 06:56:00

Twenty one of 56 pharmaceutical companies have adopted the system of more than two chief executive officers (CEO) to ensure more efficient company management, according to Yakup.com, a pharmaceutical information website.

These companies include Daewooong Pharm, Green Cross, Corp., Hanmi Pharm, JW Pharm, Ildong Pharm, Handok Pharm, Boryung Pharm, Dongwha Pharm, Samjin Pharm, Myungmoon Pharm, ...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.